Retaglutide is a novel GLP-1 receptor agonist currently under study for the treatment of obesity. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://amiegpno385739.designertoblog.com/70155452/retaglutide-a-promising-glp-1-receptor-agonist